G
enerally, medical procedures such as flexible bronchoscopy (FB) are avoided in pregnancy as a result of procedure-and sedation-related risks to the mother and the fetus. However, there are situations in which these procedures might be diagnostically or therapeutically indicated and should not be delayed.
The current published knowledge about FB in pregnancy is limited to a few case reports [1] [2] [3] [4] [5] [6] [7] [8] and one review article 9 ; however, upper and lower GI endoscopy during pregnancy is well described, and the lessons learned may be partially extrapolated to FB.
The published studies on endoscopy during pregnancy are mostly retrospective and small. 10 The only exception is a large, case-control study 11 comparing 83 pregnant women undergoing esophagogastroduodenoscopy with matched pregnant (not undergoing the procedure) and nonpregnant (undergoing the same procedure) women as control subjects. The study reported no increase in adverse events among the pregnant treatment group. However, statistical power was insufficient to exclude a small, but clinically important, fetal risk from endoscopy.
Bronchoscopy during pregnancy has its own specific risks from inserting instruments into the airway, such as impaired gas exchange, severe violent cough, and barotrauma (pneumothorax and pneumomediastinum), which may actually be more hazardous to the pregnant patient. Medications used during endoscopy, and thus bronchoscopy, seem to be responsible for many of the endoscopic risks during pregnancy, but their risks are imprecisely defined, apart from the direct effect of each drug on the fetus. In this review, we describe the major issues of performing FB in pregnant women, such as changes in the respiratory system, the potential risks associated with FB, the major indications for FB, the use of diagnostic radiation, and the monitoring of the mother and the fetus during FB. Finally, we list some general recommendations for performing bronchoscopy in pregnant patients.
Respiratory System Changes During Pregnancy
The respiratory system undergoes multiple physiologic and anatomic changes during pregnancy. The bronchoscopist should understand the implications of these changes when planning, preparing, and monitoring the procedure in pregnant women.
Functional Respiratory Changes in Pregnancy
Large airway function does not seem to change during pregnancy. 12 The respiratory centers in the brain do appear to change homeostatic set points during pregnancy, as manifested by increased respiratory drive, which is probably a function of increasing levels of progesterone. 13 The mechanism of this change is thought to involve an increasing sensitivity of the medulla to carbon dioxide, such that increases in Paco 2 elicit an exaggerated respiratory effort, although a direct effect of progesterone on the respiratory center cannot be excluded. 14 Residual volume and expiratory reserve volume 15 However, the increased inspiratory capacity results in minimal decreases in total lung capacity, and it leaves vital capacity virtually unchanged. The decrease in functional residual capacity is caused by diaphragmatic elevation (caused by increased intraabdominal pressure) and possibly by increased pulmonary blood flow. These changes likely result in increased uptake and elimination of inhalational anesthetics and with rapid oxygen desaturation during hypoventilation episodes, and this in turn makes endotracheal intubation at term more hazardous 16 Relative hyperventilation begins in the first trimester of pregnancy, with the minute ventilation rising by almost 50% at term. 17 The increase in minute ventilation is primarily the result of a large (up to 40%) increase in tidal volume; the respiratory rate does not change. 18 Pregnant women with normal respiratory rates often complain of dyspnea, which is usually the result of these respiratory adaptations. 19 Oxygen consumption increases by almost 20% during pregnancy, to meet the increased metabolic demands of the placenta, fetus, and maternal organs. However, as mentioned above, minute ventilation rises disproportionately, leading to a rise in alveolar and arterial oxygen levels (normal Pao 2 in pregnant women ranges from 100 to 110 mm Hg). 20 In addition, Paco 2 decrease from the nonpregnant average of 40 mm Hg to a plateau of 27 to 32 mm Hg during pregnancy. 13 This respiratory alkalosis is followed by compensatory renal excretion of bicarbonate so that the resultant arterial pH is normal to slightly alkalotic (usually a pH between 7.40 and 7.45). 21 The decrease in Paco 2 probably helps the fetus to eliminate carbon dioxide across the placenta.
Anatomic Respiratory Changes in Pregnancy
Increased estrogen levels during pregnancy 22 cause several changes in the upper airway mucosa, such as hyperemia, glandular hyperactivity, increased phagocytic activity, and increased mucosal mucopolysaccharide content. 23 These changes, in turn, lead to the so-called "rhinitis of pregnancy," which occurs in approximately 30% of all pregnancies, and pregnancy-induced gingivitis, which occurs in 40 to 100% of all pregnancies). 24 The result is increased mucosal edema and likelihood of bleeding, which makes the case for oral, rather than nasal, bronchoscope insertion in the pregnant women.
Changes in the thorax and abdomen appear to occur early in pregnancy, well before simple displacement from the enlarging uterus could cause such an effect. In the first trimester, the subcostal angle can change from 68°to as much as 103°. 25 The diaphragm rises by up to 4 cm, and the chest diameter can increase Ն 2 cm. 26 Diaphragmatic excursion is not limited by the uterus, and actually increases by up to 2 cm. 27 The result of these changes is a more "barrel-chested" appearance during pregnancy.
Other Changes in Pregnancy Relevant to Bronchoscopy
The increased prevalence of gastroesophageal reflux during pregnancy involves both mechanical and intrinsic factors that reduce lower esophageal sphincter tone, which in turn increases the theoretical risk of aspiration during conscious sedation and bronchoscopy. 28, 29 Uterine enlargement beyond 20 weeks of gestational age can compress the inferior vena cava, markedly reducing cardiac preload and causing the so-called "supine hypotensive syndrome" in approximately 8% of all pregnancies. 30, 31 This syndrome is characterized by the symptoms and signs of reduced cardiac output, mean arterial pressure decrease of Ͼ 15 mm Hg, and sympathetic activation, within 3 to 10 min of lying supine, and can harm the mother and the fetus. A sedated patient may not be able to respond to early warning signs appropriately. Therefore, procedures such as FB should be done with the patient in the left lateral tilt position, which is achieved by placing a wedge under the right side, having the patient lie on her left side, or adjusting the operating table to a 30°left lateral tilt 32 
Potential Risks of Bronchoscopy in Pregnancy
Risks associated with FB can be classified into those related to conscious sedation and medications and those related to the procedure itself. Risks from conscious sedation and other medications used during the procedure include medication-related teratogenesis, induction of premature labor, maternal cardiac arrhythmias, and depressed mental status with resultant hypoventilation (which in turn can cause hypoxemia), airway vulnerability, and possible pulmonary aspiration or respiratory distress. 33 Risks associated with the procedure itself generally include pneumothorax, hypoxemia, airway hyperreactivity, pulmonary hemorrhage, and systemic hypotension or hypertension. 34 The fetus is particularly sensitive to maternal hypoxia and hypotension. 35 Maternal hypoxia can result from medications, 36 vagally mediated bronchospasm, and pulmonary aspiration. 37 We found no published information on the pulmonary complications associated with FB in pregnancy.
Medications Commonly Used During Bronchoscopy and Pregnancy
Medications used during FB should be considered carefully before being administered to pregnant women, as a result of the potential risks of inducing hemodynamic effects in the mother that can affect the fetus (Table 1) . Also, the possible direct effects on the fetus, other than the other usual effects of sedatives and analgesics, must be considered ( Table 2 ).
Patient and Fetal Monitoring During Bronchoscopy
As in other procedures done under conscious sedation, monitoring of pregnant women undergoing FB under conscious sedation should include the following: (1) an initial assessment of the medical history, including previous instances of complicated conscious sedation and allergies, and a general physical examination with specific attention to airway patency; (2) continuous monitoring with intermittent sphygmomanometry, cardiac rhythm and rate monitoring, and pulse oximetry (see below); capnography is optional (see below), but special attention should be paid to the presence of apnea and hypopnea; and (3) there are no formal recommendations regarding fetal heart monitoring during FB. The few case series that address endoscopy during pregnancy suggest that fetal heart monitoring is indicated only in high-risk pregnancies or in procedures done during the third trimester. 38 However, anesthesia departments may require fetal heart monitoring during any procedure done under conscious sedation.
Pulse Oximetry
Maranetra et al 39 evaluated changes in hemoglobin oxygen saturation with pulse oximetry during diagnostic bronchoscopy in 100 patients. They reported an average oxygen desaturation of 5.6% in approximately 97% of the patients, a recuperation time of 1 to 34 min, and increased desaturation when patients were examined while seated. These findings stress the importance of pulse oximetry during bronchoscopy, especially in pregnant women, given the potential detrimental effect of hypoxemia on the fetus described above. Therefore, oxygen should be administered during the procedure to keep oxygen saturation at 97 to 100% at all times.
Capnography
Studies 40 -42 have documented the occurrence of marked hypercapnia in the absence of profound hypoxemia in patients receiving sufficient amounts of oxygen, even though these results have been put into question. In an animal study, 43 the fetal heart rate response to either hypoxemia or hypercapnia consisted of slowing and increased variability. Slowing was more consistent with hypercapnia than with hypoxemia.
Cognitive skills were lower in 26 preterm-birth preschool and early school-age children with a slightto-moderate risk for perinatal hypoxia when compared with matched control subjects; however this study 44 was retrospective and the patients had marked hypoxemia in addition to hypercapnia, and its applicability is therefore limited. Other evidence of mild and temporary respiratory acidosis effects on human fetal growth and development is lacking; however, until such evidence is obtained, hypoventilation should be avoided during procedures in pregnant women. End-tidal Paco 2 (capnometry) is a more sensitive measure of the hypoventilation that is being masked by supplemental oxygen delivery than is direct visual monitoring. 45 A controlled trial 46 evaluating this approach in 195 patients undergoing endoscopic retrograde cholangiopancreatography found that hypercapnia was not reliably detected by clinical observations or by pulse oximetry in patients receiving supplemental oxygen. The addition of transcutaneous carbon dioxide monitoring prevented severe hypercapnia more effectively than intensive clinical monitoring and pulse oximetry alone. Routine capnometry, however, is not currently widely available or included in current recommendations for monitoring patients undergoing conscious sedation. 46 
Indications for Bronchoscopy in Pregnancy
The indications for bronchoscopy in pregnant patients are similar to those for patients who are not pregnant (Table 3) . 47 
Emergent Bronchoscopy in Pregnancy
As in any other emergent situations, lifesaving procedures should be performed in pregnant women regardless of the stage of pregnancy or the status of the fetus. Emergent bronchoscopy is no exception. Emergent indications for FB include airway maintenance in cases of upper airway obstruction caused by critical subglottic-tracheal stenosis, marked lung collapse caused by an obstructing foreign body, or massive hemoptysis caused by tumors. The primary concern should be the safety and survival of the mother. However, harm to the fetus can be minimized by fetal monitoring, adequate oxygenation of the mother during the procedure, and avoiding hypotension-inducing drugs. Well-trained operators working in well-controlled settings, such as in the operating room, also decrease risk.
Nonemergent Bronchoscopy in Pregnancy
The decision to perform nonemergent bronchoscopy should be individualized to each patient and should depend on the clinical setting, indication, mother's health status, and stage of pregnancy. In addition, the following considerations are important:
• If possible, postpone diagnostic bronchoscopy until the patient has given birth. Timing will be dictated by clinical needs 47 • If possible, postpone bronchoscopy until there is good chance of delivering a viable healthy newborn, usually after 28 weeks of pregnancy.
• New technologies can, in selected cases, substitute for bronchoscopy. For example, three-dimensional CT and virtual bronchoscopy can be used to follow an endobronchial lesion in a patient who has undergone an initial diagnostic FB. However, the limitations and potential harmful effects (such as radiation, see below) of these technologies on the mother and the fetus must be kept in mind.
Radiation Exposure During Pregnancy
The potential harmful consequences of radiation for the fetus can be classified into four categories: intrauterine death, malformations, growth and developmental disturbances, and mutagenic and carcinogenic effects. 48 The danger to the fetus from radiation during fluoroscopic procedures depends on the dose of radiation (which in turn is related to exposure time, the number of films obtained, beam size, and imaging area) and gestational age. The preimplanted embryo is most at risk from the lethal effects of radiation. 49 The risk is greatly diminished by appropriate and complete abdominal lead shielding, a short radiation exposure time, and performance of the procedure after the 14th week of gestation, when organogenesis has already been achieved. A study 50 of radiation in pregnant women with appropriate abdominal shielding reported no abnormalities related to radiation.
The exact dose of radiation received during fluoroscopic FB is not known; however, a study 49 of cardiac catheterization and valvuloplasty reported no adverse fetal effects of ionizing radiation at doses of Ͻ 5 rad. The margin of safety is augmented by the fact that most exposures to diagnostic imaging radiation are spread over a period of time; this type of exposure is less harmful than acute exposure. 51 The same risk-benefit analysis should be applied when deciding to use fluoroscopy for diagnostic FB, keeping in mind that fluoroscopy does not improve the yield for transbronchial biopsy, especially in diffuse lung diseases. 52 General Recommendations for Bronchoscopy During Pregnancy the utility and safety of bronchoscopy and other associated diagnostic and therapeutic procedures during pregnancy. Until such studies are published, bronchoscopy should be reserved for indications that cannot wait until the postpartum period. Advances in the diagnosis and treatment of lung and airway diseases, such as endobronchial ultrasound, CT fluoroscopy, and virtual bronchoscopy, may be combined with FB to decrease the risks to the mother and the fetus.
